Antibodies and Immunology News and Research

Latest Antibodies and Immunology News and Research

Research uncovers key component of cellular malfunction that contributes to tumor growth

Scientists have homed in on a crucial step within the sequence of chemical reactions that govern regulation of cell division, proliferation and death, and whose malfunction contributes to the growth of tumors.

3 Nov 2021

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

Monoclonal antibodies protected aged, diabetic rhesus macaque monkeys from disease due to SARS-CoV-2 and reduced signs of inflammation, including in cerebrospinal fluid, according to a new study from researchers at the University of California, Davis.

From The University of California, Davis 2 Nov 2021

Research reveals how foodborne infections protect the gut's nervous system

A simple stomach bug could do a lot of damage. There are 100 million neurons scattered along the gastrointestinal tract-;directly in the line of fire-;that can be stamped out by gut infections, potentially leading to long-term GI disease.

1 Nov 2021

Study reveals what causes T cells to be non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

1 Nov 2021

OHSU part of new project investigating stem cell therapy as potential glaucoma treatment

Oregon Health & Science University is part of a national research project investigating stem cell therapy as a potential treatment for glaucoma, the world's second leading cause of blindness.

1 Nov 2021

Study unravels unknown facts about SARS-CoV-2 infection

Around 3%–10% of the individuals infected by the SARS-CoV-2 experience moderate to severe disease.

1 Nov 2021

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

29 Oct 2021

Discovery of long-lived mitochondrial proteins reveals increased stability of the electron transport chain

Mitochondria are known as the powerhouses of the cell, generating the energy that's needed to fuel the functions that our cells carry out.

29 Oct 2021

Novel genetic biomarkers accurately predict SARS-CoV-2 infection, says study

Researchers from the University of Colorado School of Medicine identified specific genetic biomarkers that reveal who is infected with COVID-19.

29 Oct 2021

New approach to cut off cancer cells’ food supply and kill them

Inositol is a sugar required for cells to survive. Most cells either get it from the bloodstream or make it themselves. Since there is plenty of inositol available, some cancer cells decide to stop making it.

28 Oct 2021

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Sphere Fluidics announced today that it has closed a $40 million (circa £30 million) investment round.

From Sphere Fluidics Limited 28 Oct 2021

Low dose of pollutants in food leads to high activation of antibodies that cause allergic response

Exposure to the heavy metal cadmium is known to irritate the stomach and lungs or cause kidney disease, but new research links another health issue to inadvertently ingesting low doses of the pollutant: high activation of the antibodies that cause an allergic response.

27 Oct 2021

Research reveals how cancer cells thrive by exploiting genetic and cellular processes

Writing in EMBO reports, researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe how a pair of fundamental genetic and cellular processes are exploited by cancer cells to promote tumor survival and growth.

From UC San Diego 27 Oct 2021

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Once an infection is under control, the body normally uses a biochemical messenger known as TGFβ to downgrade its immune response.

27 Oct 2021

Horse hyperimmune antibody may be an efficient approach to combat SARS-CoV-2

A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat covid-19.

27 Oct 2021

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

Today bit.bio welcomed three new members to its Board of Directors, who bring their respective experience of turning world-class science into new industries.

From bit.bio 27 Oct 2021

Study identifies a novel role for regulatory protein Bach1 in Parkinson's disease

Parkinson's disease (PD) is the most common neurodegenerative movement disorder, afflicting more than 10 million people worldwide and more than one million Americans. While there is no cure for PD, current therapies focus on treating motor symptoms and fail to reverse, or even address, the underlying neurological damage.

26 Oct 2021

New insight into how neurons and astrocytes work together to form healthy synapses

Brain cells called astrocytes play a key role in helping neurons develop and function properly, but there's still a lot scientists don't understand about how astrocytes perform these important jobs.

26 Oct 2021

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics has today announced the launch of its novel Molecular Imprinting Epitope Discovery Service.

26 Oct 2021

Targeted drug shows promise against brain metastases from kidney cancer

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet need.

22 Oct 2021

Antibodies and Immunology News and Research

Latest Antibodies and Immunology News and Research

Research uncovers key component of cellular malfunction that contributes to tumor growth

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

Research reveals how foodborne infections protect the gut's nervous system

Study reveals what causes T cells to be non-responsive to immunotherapy

OHSU part of new project investigating stem cell therapy as potential glaucoma treatment

Study unravels unknown facts about SARS-CoV-2 infection

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Discovery of long-lived mitochondrial proteins reveals increased stability of the electron transport chain

Novel genetic biomarkers accurately predict SARS-CoV-2 infection, says study

New approach to cut off cancer cells’ food supply and kill them

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Low dose of pollutants in food leads to high activation of antibodies that cause allergic response

Research reveals how cancer cells thrive by exploiting genetic and cellular processes

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Horse hyperimmune antibody may be an efficient approach to combat SARS-CoV-2

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

Study identifies a novel role for regulatory protein Bach1 in Parkinson's disease

New insight into how neurons and astrocytes work together to form healthy synapses

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

Targeted drug shows promise against brain metastases from kidney cancer

Antibodies eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Antibodies and Immunology News and Research

Latest Antibodies and Immunology News and Research

Antibodies eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Newsletters you may be interested in